Atlas Trials

Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Clinical trial NCT04161053 · RECRUITING

Trial details

NCT number
NCT04161053
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatic Encephalopathy
Start date
2018-11-01
Primary completion
2028-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.